• 1. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 2. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 3. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 4. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 5. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Compound Introduction: (NZ)-N-(4-hydroxyphenyl)methylidene-N-oxidoanilinium (CAS No. 94664-72-9)

Compound (NZ)-N-(4-hydroxyphenyl)methylidene-N-oxidoanilinium, with the CAS number 94664-72-9, is a specialized chemical entity that has garnered significant attention in the field of pharmaceutical and biochemical research. This compound belongs to a class of molecules that exhibit intriguing structural and functional properties, making it a subject of extensive study in various scientific disciplines.

The molecular structure of (NZ)-N-(4-hydroxyphenyl)methylidene-N-oxidoanilinium features a complex arrangement of atoms, including aromatic rings and functional groups that contribute to its unique chemical behavior. The presence of a 4-hydroxyphenyl moiety and an N-oxido group suggests potential roles in redox reactions and interactions with biological targets. These structural features make the compound a promising candidate for further investigation in drug discovery and molecular biology.

In recent years, the interest in this compound has been fueled by its potential applications in the development of novel therapeutic agents. Research has indicated that molecules with similar structural motifs may possess properties that are beneficial for treating various diseases, including neurological disorders and inflammatory conditions. The N-oxidoanilinium core of the compound is particularly noteworthy, as it has been associated with compounds that exhibit potent biological activity.

One of the most compelling aspects of (NZ)-N-(4-hydroxyphenyl)methylidene-N-oxidoanilinium is its ability to interact with biological systems in diverse ways. Studies have shown that this compound can modulate enzyme activity and influence cellular signaling pathways, which are critical for maintaining homeostasis and responding to pathological conditions. The hydroxyl group on the aromatic ring also suggests potential for hydrogen bonding interactions, which are essential for binding to biological targets with high specificity.

The synthesis of (NZ)-N-(4-hydroxyphenyl)methylidene-N-oxidoanilinium involves intricate chemical methodologies that require precise control over reaction conditions. The process typically involves multiple steps, including condensation reactions, oxidation, and functional group transformations. These synthetic routes highlight the compound's complexity and the expertise required to produce it in a pure form suitable for research applications.

Recent advancements in computational chemistry have enabled researchers to predict the properties and behavior of (NZ)-N-(4-hydroxyphenyl)methylidene-N-oxidoanilinium with greater accuracy. Molecular modeling studies have provided insights into how this compound might interact with proteins and other biomolecules, offering a virtual screening platform to identify potential therapeutic applications. These computational approaches complement experimental work by providing rapid and cost-effective evaluations of molecular interactions.

The pharmacological potential of (NZ)-N-(4-hydroxyphenyl)methylidene-N-oxidoanilinium has been explored in several preclinical studies. Researchers have investigated its effects on various biological systems, including its ability to inhibit inflammatory pathways and protect against oxidative stress. The compound's dual functionality—both as an oxidizing agent and as a hydrogen bond acceptor—makes it particularly interesting for developing multifaceted therapeutic strategies.

In conclusion, (NZ)-N-(4-hydroxyphenyl)methylidene-N-oxidoanilinium (CAS No. 94664-72-9) is a structurally complex and biologically relevant compound that holds significant promise for future research and development. Its unique combination of functional groups and potential interactions with biological targets make it a valuable asset in the quest for novel pharmaceutical agents. As research continues to uncover new applications for this compound, its importance in the field of medicinal chemistry is likely to grow.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)